End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,050 IDR | +0.99% | -3.17% | -43.52% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- With regards to fundamentals, the enterprise value to sales ratio is at 1218.06 for the current period. Therefore, the company is undervalued.
- The company's share price in relation to its net book value makes it look relatively cheap.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- The company is one of the best yield companies with high dividend expectations.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-43.52% | 176M | - | ||
-16.80% | 8.79B | B+ | ||
+67.50% | 4.19B | C+ | ||
-4.03% | 2.48B | B- | ||
-42.54% | 2.29B | B- | ||
-6.49% | 1.97B | C- | ||
-20.45% | 1.56B | A- | ||
-41.24% | 1.22B | C+ | ||
+10.26% | 1.13B | B+ | ||
+18.74% | 933M | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- PRDA Stock
- Ratings PT Prodia Widyahusada Tbk